Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: January 12, 2021
Sigma-1 Receptors: A Novel Clinical Target in Fragile X Syndrome
Search for trials
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Genetic
  • Participants: 36
  • Start Date: September 1, 2020
Comparison of Two NGS Phasing Techniques of Parental Haplotypes for NIPD of Triplet Expansion Diseases
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 100
  • Start Date: March 2, 2020
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 120
  • Start Date: May 24, 2019
A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome (FXS)
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 120
  • Start Date: November 30, 2018
Piloting an Early Intervention Program for Infants With Fragile X Syndrome
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Diagnostic Test
  • Participants: 11500
  • Start Date: October 15, 2018
Early Check: A Collaborative Innovation to Facilitate Pre-Symptomatic Clinical Trials in Newborns
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: April 30, 2018
A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement, Other
  • Participants: 70
  • Start Date: January 29, 2018
Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)
Showing 1-12 of 20